These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37855644)

  • 21. Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension.
    Gadelha M; Snyder PJ; Witek P; Bex M; Belaya Z; Turcu AF; Feelders RA; Heaney AP; Paul M; Pedroncelli AM; Auchus RJ
    Front Endocrinol (Lausanne); 2023; 14():1236465. PubMed ID: 37680892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Catastrophic ACTH-secreting pheochromocytoma: an uncommon and challenging entity with multifaceted presentation.
    Foppiani L; Poeta MG; Rutigliani M; Parodi S; Catrambone U; Cavalleri L; Antonucci G; Del Monte P; Piccardo A
    Endocrinol Diabetes Metab Case Rep; 2023 May; 2023(2):. PubMed ID: 37162230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment for adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with laparoscopic adrenalectomy: a case series.
    Ito T; Kurita Y; Shinbo H; Otsuka A; Furuse H; Mugiya S; Ushiyama T; Ozono S; Oki Y; Suzuki K
    J Med Case Rep; 2012 Sep; 6():312. PubMed ID: 22989371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticotroph tumor progression during long-term therapy with osilodrostat in a patient with persistent Cushing's disease.
    Fontaine-Sylvestre C; Létourneau-Guillon L; Moumdjian RA; Berthelet F; Lacroix A
    Pituitary; 2021 Apr; 24(2):207-215. PubMed ID: 33074401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ectopic production of ACTH and corticotropin-releasing hormone (CRH).
    Müller OA; von Werder K
    J Steroid Biochem Mol Biol; 1992 Oct; 43(5):403-8. PubMed ID: 1327073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological Treatment of Cushing's Syndrome.
    Castinetti F
    Arch Med Res; 2023 Dec; 54(8):102908. PubMed ID: 37977919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A rare case of an ACTH/CRH co-secreting midgut neuroendocrine tumor mimicking Cushing's disease.
    Streuli R; Krull I; Brändle M; Kolb W; Stalla G; Theodoropoulou M; Enzler-Tschudy A; Bilz S
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28680643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Posterior reversible encephalopathy syndrome in a patient with a metastatic pancreatic neuroendocrine tumour and ectopic Cushing's syndrome.
    Palmer K; Weerasuriya S; Whitelaw B; Srirajaskanthan R
    Endocrinol Diabetes Metab Case Rep; 2021 Apr; 2021():. PubMed ID: 33859057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.
    Dormoy A; Haissaguerre M; Vitellius G; Do Cao C; Geslot A; Drui D; Lasolle H; Vieira-Pinto O; Salenave S; François M; Puerto M; Boullay HD; Mayer A; Rod A; Laurent C; Chanson P; Reznik Y; Castinetti F; Chabre O; Baudin E; Raverot G; Tabarin A; Young J
    J Clin Endocrinol Metab; 2023 May; 108(6):1475-1487. PubMed ID: 36470583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4).
    Shimatsu A; Biller BM; Fleseriu M; Pivonello R; Lee EJ; Leelawattana R; Kim JH; Walia R; Yu Y; Liao Z; Piacentini A; Pedroncelli AM; Snyder PJ
    Endocr J; 2024 Dec; 71(12):1103-1123. PubMed ID: 39183039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.
    Reincke M; Ritzel K; Oßwald A; Berr C; Stalla G; Hallfeldt K; Reisch N; Schopohl J; Beuschlein F
    Eur J Endocrinol; 2015 Oct; 173(4):M23-32. PubMed ID: 25994948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corticotropin-dependent Cushing's syndrome in older people: presentation of five cases and therapeutical use of ketoconazole.
    Berwaerts JJ; Verhelst JA; Verhaert GC; Verhaegen AA; Abs RE
    J Am Geriatr Soc; 1998 Jul; 46(7):880-4. PubMed ID: 9670876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Osilodrostat: A Novel Potent Inhibitor of 11-Beta-Hydroxylase for the Treatment of Cushing's Syndrome.
    Pivonello R; Simeoli C; Paola ND; Larocca A; Crescenzo EM; Colao A
    touchREV Endocrinol; 2024 Apr; 20(1):43-51. PubMed ID: 38812665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged adrenal insufficiency following discontinuation of osilodrostat treatment for intense hypercortisolism.
    Ferriere A; Salenave S; Puerto M; Young J; Tabarin A
    Eur J Endocrinol; 2024 Jan; 190(1):L1-L3. PubMed ID: 38123490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease.
    Pivonello R; Fleseriu M; Newell-Price J; Shimatsu A; Feelders RA; Kadioglu P; Tabarin A; Brue TC; Geer EB; Piacentini A; Pedroncelli AM; Biller BMK
    J Endocrinol Invest; 2024 Oct; 47(10):2437-2448. PubMed ID: 38696122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osilodrostat for the treatment of Cushing's disease.
    Rasool S; Skinner BW
    Expert Opin Pharmacother; 2021 Jun; 22(9):1099-1106. PubMed ID: 33703978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies.
    Fleseriu M; Castinetti F
    Pituitary; 2016 Dec; 19(6):643-653. PubMed ID: 27600150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Updates in adrenal steroidogenesis inhibitors for Cushing's syndrome - A practical guide.
    Varlamov EV; Han AJ; Fleseriu M
    Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101490. PubMed ID: 33707082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.